Policyholder Services



TRIA Reauthorized and OMIC’s Terrorism Insurance Coverage Endorsement Reinstated

Congress passed the Terrorism Risk Insurance Act (TRIA) in 2002, creating a temporary federal “backstop” for insurance claims related to acts of terrorism. It had been extended several times, and expired 12/31/2014. However, Congress recently passed and the President signed into law a reauthorization bill extending TRIA through 2020. Therefore, OMIC has reinstated the Terrorism Insurance Coverage Endorsement (OMC162), which was briefly removed from all OMIC policies when TRIA expired. This endorsement covers otherwise insured damages arising out of certified acts of terrorism. OMIC provides this benefit to all of its policyholders free of charge. The reauthorization legislation made some changes to the program. It decreases the federal share of compensation for insured losses from 85% to 80% and raises the program trigger amount in total losses from $100 million to $200 million, both incrementally over five years. OMIC has revised its Endorsement OMC162, effective 1/1/2015, accordingly. See it here: TRIA Endorsement OMC162 1 17 2015.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684